Home / Inspections / 788561

FDA Inspection 788561 — AstraZeneca Pharmaceuticals, LP

AstraZeneca Pharmaceuticals, LP — FEI 2517100

The FDA completed an inspection of AstraZeneca Pharmaceuticals, LP on November 28, 2011 in Newark, DE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 28, 2011
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Newark, DE (United States)

Facility

Other inspections at this facility

  • 1211584 (NAI Wed Jul 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1022686 (NAI Thu Aug 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 895233 (VAI Wed Aug 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 737328 (VAI Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 611523 (NAI Thu Sep 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources